AA

Healthcare · Pharmaceuticals

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS)

₹116.03

Mkt cap
₹343 Cr
P/E ratio
76.00
P/B
2.18
Div yield
0.00%
ROE
2.75%
ROCE
5.58%
EPS (TTM)
₹1.53
Book value
₹53
52W range
50–117
Sector
Healthcare

Price history

Previous close

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse industrial applications [1]

NSE AAREYDRUGSBSE 524412
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsBullish
52-week range
−0.74% from high
₹116
₹50+130.63% from low₹117
Current
₹116.03
Prev close
₹112.20
Day
+3.41%
Price performance
1D
+3.30%
1W
+0.65%
1M
+4.97%
3M
+43.81%
6M
+41.29%
1Y
+20.73%
YTD
+74.90%

Financials

Revenue, profit & margin
P/E ratio
76.0×
AAREYDRUGS is 132% above the sector median of 32.8×
AAREYDRUGS76.0×
Sector median32.8×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales57.8376.48210.35126.91105.14133.79108.10102.2184.1696.43189.4744.6388.62
YoY Sales growth-24.17%+22.43%+29.14%+149.04%+81.81%+74.93%-48.61%-19.46%-19.95%-27.92%+75.27%-56.33%+5.30%
Expenses55.9973.78211.79125.73101.42131.59112.31100.5081.5297.94185.1343.3186.48
Operating Profit1.842.70-1.441.183.722.20-4.211.712.64-1.514.341.322.14
OPM %3.18%3.53%-0.68%0.93%3.54%1.64%-3.89%1.67%3.14%-1.57%2.29%2.96%2.41%
Other Income0.840.295.141.580.020.687.541.550.794.18-0.431.721.62
Interest0.410.470.400.960.490.581.301.041.260.921.781.671.16
Depreciation1.271.061.150.471.510.900.410.490.690.830.850.850.94
Profit before tax1.001.462.151.331.741.401.621.731.480.921.280.521.66
Tax %-22.00%30.14%-0.47%6.77%8.62%48.57%71.60%20.81%31.08%38.04%-21.88%-98.08%17.47%
Net Profit1.231.022.151.241.600.720.471.371.020.571.561.021.37
EPS in Rs0.480.400.770.440.570.250.170.480.360.200.550.360.43
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +2.04% · closed higher next day 0 of last 1
 Q1FY27
Broadcast14 Aug '26◦
Earnings day+2.04%
+1 day−2.04%
+5 days−6.88%
+15 days+16.02%
+30 days+19.14%
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
41.46%Promoter
Promoters41.46%3.75
FIIs4.28%0.53
DIIs1.44%0.18
Public52.83%3.04
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,871.5036.494,49,0360.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,049.0085.832,93,3160.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,610.7080.781,75,3760.82%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,322.5093.661,25,4880.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,202.0026.461,19,9000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,398.2041.711,16,7880.57%913−31.35%8,698−1.48%13.04%
Cipla₹1,417.0036.861,14,4780.92%852−35.05%7,404−2.44%15.49%
Aarey Drugs₹107.7575.983430.00%1+34.31%89+5.30%5.58%
Median: 160 Co.₹439.3232.752,0010.08%13+33.73%179+21.23%14.94%

Filings